Skip to content
Monday, November 16, 2026
Netraland UK provides unbiased technology reviews, digital …

Administering Pluripotent Cells During Pregnancy to Babies with Neural Tube Defect Boosts Quality of Life, Trial Finds

An innovative clinical study has found that providing pluripotent cells to developing infants suffering from spina bifida while undergoing fetal surgery could constitute a "important advancement" in treating birth defects.

Trial Details and Safety

The US-based trial involved six unborn babies with a severe neural tube defect. Surgeons applied regenerative cells sourced from the maternal placenta to the surface of the baby's spinal cord while the defect was being closed.

Significantly, the regenerative treatment was found to be safe. Doctors verified that the treatment did not lead to neoplasms, interfere with wound healing, or impede the resolution of associated brain abnormalities.

Encouraging Results

Magnetic resonance imaging performed on the newborns showed a complete reversal of hindbrain herniation in every participant. This favorable anatomical change is closely linked to better mobility and function.

"In the event it allows more children able to walk who otherwise would not, it may emerge as the conventional approach," said the lead researcher. "The outcomes appear super exciting and pave the way for a variety of prospective new treatments."

Future Implications and Hope

Experts not involved in the trial have suggested that further confirmation of these noted improvements could herald a "different age" in fetal surgery. The possibility of ameliorating neurological damage occurring during fetal development is considered a paradigm-shifting aim.

Particularly welcome would be advancements for continence and digestive health, which are common challenges for people affected by this disorder.

The Path Forward

Despite this being a first-in-human effort was small in scale, its safety demonstration and positive signals provide a strong foundation for larger, more comprehensive studies. The integration of stem cell therapy with established fetal surgery techniques offers substantial hope for changing life trajectories for babies yet to be born with spina bifida.

JS
The writer

Jessica Sherman

A cybersecurity consultant and tech writer with over a decade of experience in digital transformation and data privacy regulations across Europe.

Netraland

Type to search articles.